![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Pharma Blog Watch
Pharma Blog Watch
August 21, 2006
Barr Re-Files for Plan
B (Eye on FDA)
In his blog, Mark Senak writes that if Andrew von Eschenbach, acting FDA commissioner,
were to finally approve Plan B, it would not only prove he can lead the agency,
but it would restore credibility to the FDA.
Risk Management Plans
(Drug Wonks)
In his entry, blogger Robert Goldberg discusses the problematic risk management
plan in place for the acne drug isotretinoin, which can cause birth defects.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct